Company Search:
Advanced Search
Sponsored Links
Pharmacyte Biotech Inc Company Snapshot
Pharmacyte Biotech Inc operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pharmacyte Biotech Inc with three other pharmaceutical manufacturers in North America: Histogenics Corp (2013 sales of $8,000.00 of which 100% was Regenerative Medicine), Imprimis Pharmaceuticals Incorporated ($10,000.00 of which 100% was Pharmaceuticals), and Palatin Technologies, Inc. ($10,361.00 of which 100% was Licenses, Grants and Contracts).

Sales Analysis. Sales fell dramatically in 2013: During the year ended April of 2013, sales at Pharmacyte Biotech Inc were $12,160.00 . This is a sharp decrease of 81.7% versus 2012, when the company's sales were $66,558.00 .
  Stock Performance Chart for Pharmacyte Biotech Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): .07
(Figures in U.S. Dollars)
1 Week 4.9%   13 Weeks 31.3%  
4 Weeks 25.2%   52 Weeks -39.4%  
Pharmacyte Biotech Inc Key Data:
  Ticker: PMCB Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2013 Sales 12,160
(Year Ending Jan 2014).
Employees: 4
  Currency: U.S. Dollars Market Cap: 69,033,048
  Fiscal Yr Ends: April Shares Outstanding: 973,667,811
  Share Type: Common Closely Held Shares: 37,200,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.